Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39324

DNAJC6 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DNAJC6 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population from HEK293T cells, engineered to disrupt the DNAJC6 gene encoding auxilin. Auxilin recruits Hsc70 to clathrin coats, stimulating clathrin disassembly in endocytosis, and is regulated by LRRK2 kinase. This model is suitable for investigating clathrin-mediated endocytosis defects, Parkinson disease mechanisms, synaptic vesicle recycling, and high-throughput drug screening. Key assays include Western blot, transferrin uptake, co-immunoprecipitation, and in vitro clathrin uncoating assays to study auxilin interactions with Hsc70, AP-2, and to assess clathrin coat dynamics.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DNAJC6

    Gene Identifier

    NCBI Gene ID 9829

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC6 Knockout HEK293T Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal population derived from the widely used HEK293T human embryonic kidney cell line, engineered to disrupt the DNAJC6 gene. This polyclonal knockout cell population provides a heterogeneous pool of gene-edited cells, enabling loss-of-function studies without the constraints of clonal selection. The CRISPR/Cas9-mediated gene disruption targets the DNAJC6 locus, generating a versatile knockout model while preserving the advantageous features of the parental HEK293T line.

HEK293T cells are a derivative of the HEK293 lineage, stably expressing the SV40 large T antigen. This expression permits episomal replication of transfected plasmids containing the SV40 origin of replication, thereby enhancing protein production in transient transfection assays. As adherent, epithelial-derived cells with robust growth characteristics and high transfection efficiency, HEK293T cells serve as a standard platform for recombinant protein expression, lentivirus and retrovirus production, and a broad spectrum of molecular and cellular assays. Their embryonic kidney origin provides a context for studying general eukaryotic cell biology processes, including endocytosis and signal transduction.

DNAJC6 encodes auxilin, a co-chaperone that recruits the constitutively expressed heat shock cognate 70 (Hsc70/HSPA8) to clathrin-coated vesicles. Auxilin stimulates Hsc70-mediated ATP hydrolysis, driving the uncoating of clathrin cages from endocytic vesicles, a critical step in clathrin-mediated endocytosis and synaptic vesicle recycling. This process is regulated upstream by the leucine-rich repeat kinase 2 (LRRK2), a kinase associated with Parkinson disease pathology. Auxilin functions within a macromolecular complex that includes clathrin heavy chain, the adaptor protein AP-2, and the GTPase dynamin. Loss of auxilin disrupts the clathrin disassembly cycle, providing a direct link between endocytic dysfunction and neurodegeneration.

In the HEK293T background, which lacks neuron-specific synaptic machinery, the DNAJC6 knockout model is particularly valuable for dissecting the general mechanistic aspects of clathrin-mediated endocytosis and chaperone-dependent vesicle trafficking. Although HEK293T cells are not neuronal, they express the core endocytic machinery and Hsc70, enabling detailed biochemical studies of auxilin function. The polyclonal nature of the knockout population introduces genetic heterogeneity that can reveal dominant effects of gene disruption while mitigating clonal artifacts. This model thus serves as a reductionist system to investigate how auxilin-dependent uncoating impacts overall endocytic flux and to identify small molecules that may compensate for auxilin loss.

Typical applications include modeling molecular deficits relevant to juvenile Parkinson disease and other neurodegenerative disorders, screening for pharmacological modulators of clathrin uncoating, and dissecting the Hsc70-auxilin interaction. Representative assays compatible with this polyclonal knockout system include Western blotting and immunofluorescence to confirm DNAJC6 ablation, co-immunoprecipitation to assess protein interactions, in vitro clathrin uncoating assays, and transferrin uptake assays to monitor endocytic efficiency. The cells can also be adapted for synaptic vesicle recycling assays with exogenous neuronal components. For additional technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)